Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections.
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
Background: Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID consultation and mortality following various MDRO infections. Methods: This study was conducted with a retrospective cohort (January 1, 2006–October 1, 2015) at an academic tertiary referral center. We identified patients with MDROs in a sterile site or bronchoalveolar lavage/bronchial wash culture. Mortality and readmissions within 1 year of index culture were identified, and the association of ID consultation with these outcomes was determined using Cox proportional hazards models with inverse weighting by the propensity score for ID consultation. Results: A total of 4214 patients with MDRO infections were identified. ID consultation was significantly associated with reductions in 30-day and 1-year mortality for resistant S. aureus (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.36–0.63; and HR, 0.73, 95% CI, 0.61–0.86) and Enterobacteriaceae (HR, 0.41; 95% CI, 0.27–0.64; and HR, 0.74; 95% CI, 0.59–0.94), and 30-day mortality for polymicrobial infections (HR, 0.51; 95% CI, 0.31–0.86) but not Acinetobacter or Pseudomonas. For resistant Enterococcus, ID consultation was marginally associated with decreased 30-day mortality (HR, 0.81; 95% CI, 0.62–1.06). ID consultation was associated with reduced 30-day readmission for resistant Enterobacteriaceae. Conclusions: ID consultation was associated with significant reductions in 30-day and 1-year mortality for resistant S. aureus and Enterobacteriaceae, and 30-day mortality for polymicrobial infections. There was no association between ID consultation and mortality for patients with resistant Pseudomonas, Acinetobacter, or Enterococcus, possibly due to small sample sizes. Our results suggest that ID consultation may be beneficial for patients with some MDRO infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specialist consultation appears to be associated with improved patient outcomes for a variety of infectious syndromes [295–300].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“10 considered evidence of imbalance [20].”
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
Self-citationNathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Self-citationBai, A. D., Showler, A., Burry, L., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M., Fernando, E., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ120 · Cited by 254
Kollef, K. E., Schramm, G. E., Wills, A. R., Reichley, R. M., Micek, S. T., & Kollef, M. H. (2008) · Chest · doi:10.1378/chest.08-1116 · Cited by 237
Self-citationVogel, M., Schmitz, R. P. H., Hagel, S., Pletz, M. W., Gagelmann, N., Scherag, A., Schlattmann, P., & Brunkhorst, F. M. (2016) · Journal of Infection · doi:10.1016/j.jinf.2015.09.037 · Cited by 227
Faurot, K. R., Jonsson Funk, M., Pate, V., Brookhart, M. A., Patrick, A., Hanson, L. C., Castillo, W. C., & Stürmer, T. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3719 · Cited by 178
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence
Tansarli, G. S., Karageorgopoulos, D. E., Kapaskelis, A., & Falagas, M. E. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.4 · Cited by 109
Hamandi, B., Husain, S., Humar, A., & Papadimitropoulos, E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu522 · Cited by 104
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
Tissot, F., Calandra, T., Prod’hom, G., Taffé, P., Zanetti, G. M. R., Greub, G., & Senn, L. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.004 · Cited by 75
Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital Cohort
Butler, A. M., Olsen, M. A. A., Merz, L. R., Guth, R. M., Woeltje, K. F., Camins, B. C., & Fraser, V. J. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/649020 · Cited by 62
Self-citationShorr, A. F., Zilberberg, M. D., Micek, S. T., & Kollef, M. H. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0572-6 · Cited by 56
Self-citationSpec, A., Olsen, M. A., Raval, K., & Powderly, W. G. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw786 · Cited by 53
Self-citationArnaud, I., Maugat, S., Jarlier, V., Astagneau, P., Warning, F. T. N. E., & Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.36.30014 · Cited by 47
Guillamet, C. V., Vazquez, R., Noe, J., Micek, S. T., & Kollef, M. H. (2016) · Medicine · doi:10.1097/md.0000000000004708 · Cited by 41
Self-citationTurner, R. B., Valcarlos, E., Won, R., Chang, E., & Schwartz, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00439-16 · Cited by 32
Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection
Burnham, J. P., Kwon, J. H., Olsen, M. A. A., Babcock, H. M., & Kollef, M. H. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.254 · Cited by 29
Self-citationShu, J., Chia, J.-H., Kuo, A.-J., SU, L. H., & Wu, T. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990409 · Cited by 28
Burnham, J. P., Burnham, C. D., Warren, D. K., & Kollef, M. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-16 · Cited by 16
Self-citation
Research works printed but not linked: 2
- CDC, Unusual Susceptibility Profiles Alert
- Multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) Module
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Gardiner, B. J., Stewardson, A. J., Abbott, I. J., & Peleg, A. Y. (2019) · Australian Prescriber · doi:10.18773/austprescr.2019.002 · Cited by 167
Microbial Resistance to Antibiotics and Effective Antibiotherapy
Chiş, A. A., Rus, L. L., Morgovan, C., Arseniu, A. M., Frum, A., Vonica-Țincu, A. L., Gligor, F. G., Mureșan, M.-L., & Dobrea, C. M. (2022) · Biomedicines · doi:10.3390/biomedicines10051121 · Cited by 150
Role of the Pharmacist in Antimicrobial Stewardship
Parente, D. M., & Morton, J. B. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.05.009 · Cited by 134
Metadata
- Authors
- Burnham, J. P., Olsen, M. A., Stwalley, D., Kwon, J. H., Babcock, H. M., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Burnham, Jason P
- ORCID
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-01
- Volume
- 5
- Issue
- 3
- Pages
- ofy026-ofy026
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC5852998
- OpenAlex
- W2793814333
- Semantic Scholar
- 4589fb9304d7f66245829f29be9c42d9c1c3eebc
- Cited by
- 90
- References
- 30
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 15 · 2019: 17 · 2018: 10
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- Washington University Institute of Clinical and Translational Sciences (UL1TR000448, KL2TR000450)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- multidrug-resistant organisms, infectious disease consultation, mortality, hospital readmission, co-infection, Acinetobacter, Pseudomonas, intensive care unit, antimicrobial resistance, 30-day mortality, one-year mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.